Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in March 2022

European Healthtech startup funding raised during March 2022.

In March 2022, 46 European Healthtech companies closed 46 funding rounds and raised €416M in equity funding (excluding debt and grants), down 16.3% versus March 2021. Debt rounds added €500M. France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.

Equity funding
€416M
-16.3% vs March 2021 · excl. debt & grants · +€500M debt
Funding rounds
46
+35.3% vs March 2021
Companies
46
Top country
France
Rank among sectors
#5
9.6% of sector funding
Debt financing
€500M
54.6% of total
Top-10 round share
88.2%
of disclosed capital
Rounds ≥ €100M
1

Top countries

by € raised
Healthtech — top countries by capital, March 2022 — interactive chart.
Data table
Healthtech — top countries by capital, March 2022
France€542M
UK€141M
Belgium€83M
Netherlands€67M
Italy€29M
Germany€28M
Switzerland€11M
Sweden€8.0M

Stage mix

by € raised
Healthtech — stage mix, March 2022 — interactive chart.
Data table
Healthtech — stage mix, March 2022
Debt€500M
Series B€255M
Other€89M
Series A€60M
Seed€8.3M
Pre-Seed€2.7M
Crowdfunding€500k
Grant€359k

Exits & M&A

5 Acquisition

5 exits.

Top deals

largest disclosed rounds in March 2022
CompanyStageDateAmount
DoctolibDebtMar 2022€500M
PrecirixSeries BMar 2022€80M
MicrobioticaSeries BMar 2022€61M
EpsilogenSeries BMar 2022€37M
In OvoSeries BMar 2022€34M
Scenic BiotechSeries AMar 2022€28M
Synapse MedicineSeries BMar 2022€25M
Kither BiotechSeries BMar 2022€19M
LantumOtherMar 2022€14M
LenioBioSeries AMar 2022€12M
Vira HealthOtherMar 2022€11M
Sano GeneticsSeries AMar 2022€10M
Core BiogenesisOtherMar 2022€10M
DiademOtherMar 2022€10M
DasLabOtherMar 2022€6.2M

Top investors

most active in March 2022, by deal count